Initial Clinical Results of a New Telescopic IOL Implanted in Patients With Dry Age-Related Macular Degeneration
Journal of refractive surgery (Thorofare, N.J. : 1995) | 10 Mar 2015
FH Hengerer, P Artal, T Kohnen and I Conrad-Hengerer
To evaluate the safety and efficacy of the iol-AMD technology (London Eye Hospital Pharma, London, UK), which includes two injectable, hydrophobic acrylic intraocular lenses (IOLs) in a pilot study of patients diagnosed as having cataract and dry age-related macular degeneration.
* Data courtesy of Altmetric.com